Novartis gets CDSCO panel okay for phase 3 trial of Secukimunab Dr. Divya Colin23 Feb 2022 3:10 PM ISTNew Delhi: The pharmaceutical major, Novartis, has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Novartis Healthcare gets CDSCO panel nod to market anti cancer drug Dabrafenib Susmita Roy19 Feb 2022 5:49 PM ISTNew Delhi: In a significant development, pharmaceutical major Novartis Healthcare has got a go ahead from the Subject Expert Committee (SEC) of the...
Health Bulletin 12/February/2022 Ruchika Sharma12 Feb 2022 5:44 PM ISTHere are Top Health stories of the dayHijab controversy: Bidar medical college director denies stopping students at exam hall Only Candidates With...
Dr Reddy's to now sell Novartis top brand Voveran Ruchika Sharma12 Feb 2022 11:57 AM ISTHyderabad: Drugmaker, Dr. Reddy's Laboratories Ltd., has recently announced that the company has entered into an exclusive sales and distribution...
Novartis Sandoz unit may be a tough pill for buyers to swallow: Bloomberg Ruchika Sharma4 Feb 2022 3:06 PM ISTNew Delhi: Novartis AG expects revenue at its generic-drugs unit to continue declining in the U.S. throughout this year, highlighting some of the...
Novartis pushes forward with Covid drug after positive trial: Bloomberg Ruchika Sharma12 Jan 2022 2:11 PM ISTNovartis's medicine is given via an intravenous infusion, making a doctor's visit necessary.
Novartis wins appeal over MS drug Gilenya patent: Bloomberg Medical Dialogues Bureau5 Jan 2022 10:00 AM ISTThe issue on appeal was whether the patent clearly explained the dosage regimen for fingolimod, the active ingredient in Gilenya, without the need for...
Novartis Cosentyx gets USFDA approval Ruchika Sharma26 Dec 2021 9:45 AM ISTBasel: Novartis has announced the US Food and Drug Administration (USFDA) has approved Cosentyx (secukinumab) for the treatment of active...
Working on pan-coronavirus oral treatment: Novartis CEO Ruchika Sharma7 Dec 2021 2:46 PM ISTNew Delhi: Novartis hopes to still play a role in the development of COVID-19 treatments with research ongoing for a pill that could work broadly...
Delhi HC restrains 4 pharma firms from making, selling 2 Novartis patent drugs Roshni Dhar10 Nov 2021 12:24 AM ISTIn a major relief to Novartis, the Delhi High Court has restrained various generic pharmaceutical companies from manufacturing or selling Valsartan...
Health Bulletin 8 / November /2021 Roshni Dhar8 Nov 2021 4:53 PM ISTHere are Top Health Stories of the day Patient Dies Post Delivery Due to Heavy Bleeding: Consumer Court Slaps Hospital, Gynecologist, Surgeon with ...
Novartis, Dunad Therapeutics ink USD 1.3 billion protein degradation deal Ruchika Sharma4 Nov 2021 9:00 AM ISTCambridge: Dunad Therapeutics has recently announced that the company has entered a strategic collaboration and license agreement with Novartis to...
